- US-listed companies
- Elevance Health, Inc.
- Income statement
Elevance Health, Inc.ELV
Market cap
$77.1B
P/E ratio
| 2010/12 | 2011/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 58,802 | 60,711 | 71,024 | 73,874 | 79,157 | 84,863 | 90,039 | 92,105 | 104,213 | 121,867 | 138,639 | 156,595 | - | 177,011 |
| Revenue growth (%) | - | - | - | - | ||||||||||
| Cost of revenue | - | - | - | - | - | - | - | - | 1,992 | 8,953 | 10,895 | 13,035 | - | 19,750 |
| Selling, general & administrative | 8,839 | 8,436 | 9,953 | 11,748 | 12,535 | 12,558 | 12,650 | 14,020 | 13,364 | 17,450 | 15,914 | 17,686 | - | 20,025 |
| Income before tax | 4,354 | 3,958 | 3,840 | 4,368 | 4,631 | 4,555 | 3,964 | 5,068 | 5,985 | 6,238 | 7,925 | 7,769 | - | 7,904 |
| Pretax margin (%) | 7.4 | 6.5 | 5.4 | 5.9 | 5.9 | 5.4 | 4.4 | 5.5 | 5.7 | 5.1 | 5.7 | 5 | - | 4.5 |
| Provision for income taxes | 1,467 | 1,311 | - | 1,808 | 2,071 | 2,086 | 121 | 1,318 | 1,178 | 1,666 | 1,830 | 1,750 | - | 1,933 |
| Effective tax rate (%) | - | - | ||||||||||||
| Net income | 2,887 | 2,647 | 2,490 | 2,570 | 2,560 | 2,470 | 3,843 | 3,750 | 4,807 | 4,572 | 6,104 | 6,025 | - | 5,980 |
| Net income margin (%) | - | |||||||||||||
| Earnings per share | 7.03 | 7.35 | 8.34 | 9.31 | 9.73 | 9.39 | 14.7 | 14.53 | 18.81 | 18.23 | 25.04 | 25.1 | - | 25.81 |
| Diluted EPS | 6.94 | 7.25 | 8.2 | 8.99 | 9.38 | 9.21 | 14.35 | 14.19 | 18.47 | 17.98 | 24.73 | 24.81 | - | 25.68 |
| Dividend payout ratio (%) | - | - | - | |||||||||||
| Dividend per share | - | 1 | 1.5 | 1.75 | 2.5 | 2.6 | 2.7 | 3 | 3.2 | 3.8 | 4.52 | 5.12 | 5.92 | - |